PTGX
Protagonist Therapeutics, Inc. · Healthcare · Biotechnology
Last
$87.21
−$0.05 (−0.06%) 4:00 PM ET
After hours
$87.23
+$0.02 (+0.02%) 8:31 PM ET
Prev close $87.26
Open $86.47
Day high $87.82
Day low $85.22
Volume 750,584
Avg vol 916,515
Mkt cap
$5.46B
P/E ratio
134.17
FY Revenue
$209.22M
EPS
0.65
Gross Margin
100.00%
Sector
Healthcare
AI report sections
PTGX
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. demonstrates robust upward momentum supported by strong technical breakouts and high trading volume, while maintaining solid fundamental health and revenue growth prospects. However, valuation metrics remain elevated and short interest is significant, and there are mixed technical reversal signals that temper the bullish outlook.
AI summarized at 8:26 PM ET, 2025-08-27
Volume vs average
Intraday (cumulative)
+27% (Above avg)
Vol/Avg: 1.27×
RSI
49.54 (Neutral)
Neutral (30–70): momentum balanced.
MACD momentum
Intraday
+0.03 (Strong)
MACD: 0.28 Signal: 0.25
Short-Term
-0.69 (Weak)
MACD: 0.71 Signal: 1.40
Long-Term
-0.74 (Weak)
MACD: 3.70 Signal: 4.44
Intraday trend score 60.00
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal